These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7488277)

  • 41. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
    Yazici Y; Bergman M; Pincus T
    J Rheumatol; 2008 Apr; 35(4):603-9. PubMed ID: 18322993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis.
    Pillemer SR; Fowler SE; Tilley BC; Alarcón GS; Heyse SP; Trentham DE; Neuner R; Clegg DO; Leisen JC; Cooper SM; Duncan H; Tuttleman M
    Arthritis Rheum; 1997 Mar; 40(3):419-25. PubMed ID: 9082927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
    Bresnihan B; Alvaro-Gracia JM; Cobby M; Doherty M; Domljan Z; Emery P; Nuki G; Pavelka K; Rau R; Rozman B; Watt I; Williams B; Aitchison R; McCabe D; Musikic P
    Arthritis Rheum; 1998 Dec; 41(12):2196-204. PubMed ID: 9870876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new disease activity index for rheumatoid arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA).
    Mäkinen H; Kautiainen H; Hannonen P; Sokka T
    J Rheumatol; 2008 Aug; 35(8):1522-7. PubMed ID: 18484699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate.
    Ogrendik M
    South Med J; 2007 Feb; 100(2):135-9. PubMed ID: 17330681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy.
    Cohen SB; Strand V; Aguilar D; Ofman JJ
    Rheumatology (Oxford); 2004 Jun; 43(6):704-11. PubMed ID: 14997006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient-reported outcomes as predictors of remission in early rheumatoid arthritis patients treated with tight control treat-to-target approach.
    Kuusalo L; Puolakka K; Kautiainen H; Karjalainen A; Malmi T; Yli-Kerttula T; Leirisalo-Repo M; Rantalaiho V;
    Rheumatol Int; 2017 May; 37(5):825-830. PubMed ID: 28289873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.
    Lan JL; Chou SJ; Chen DY; Chen YH; Hsieh TY; Young M
    J Formos Med Assoc; 2004 Aug; 103(8):618-23. PubMed ID: 15340661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index.
    Salaffi F; Stancati A; Neri R; Grassi W; Bombardieri S
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S31-42. PubMed ID: 16273783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group.
    Stein CM; Pincus T; Yocum D; Tugwell P; Wells G; Gluck O; Kraag G; Torley H; Tesser J; McKendry R; Brooks RH
    Arthritis Rheum; 1997 Oct; 40(10):1843-51. PubMed ID: 9336420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Why not use OSRA? A comparison of Overall Status in Rheumatoid Arthritis (RA) with ACR core set and other indices of disease activity in RA.
    Birrell FN; Hassell AB; Jones PW; Dawes PT
    J Rheumatol; 1998 Sep; 25(9):1709-15. PubMed ID: 9733450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial.
    Song YW; Lee EY; Koh EM; Cha HS; Yoo B; Lee CK; Baek HJ; Kim HA; Suh Y; Kang SW; Lee YJ; Jung HG
    Clin Ther; 2007 May; 29(5):862-873. PubMed ID: 17697905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis.
    Zhang LL; Wei W; Xiao F; Xu JH; Bao CD; Ni LQ; Li XF
    Arthritis Rheum; 2008 Jul; 59(7):905-10. PubMed ID: 18576295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
    Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS
    J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.
    van Vollenhoven RF; Fleischmann R; Cohen S; Lee EB; García Meijide JA; Wagner S; Forejtova S; Zwillich SH; Gruben D; Koncz T; Wallenstein GV; Krishnaswami S; Bradley JD; Wilkinson B;
    N Engl J Med; 2012 Aug; 367(6):508-19. PubMed ID: 22873531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
    Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LH; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landewé R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M
    Ann Rheum Dis; 2011 Mar; 70(3):404-13. PubMed ID: 21292833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials.
    Pincus T; Amara I; Segurado OG; Bergman M; Koch GG
    J Rheumatol; 2008 Feb; 35(2):201-5. PubMed ID: 18050378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating the Korean version of the Multidimensional Health Assessment Questionnaire in patients with rheumatoid arthritis.
    Lee SS; Park MJ; Yoon HJ; Park YW; Park IH; Park KS
    Clin Rheumatol; 2006 May; 25(3):353-7. PubMed ID: 16273310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generic quality-of-life assessment in rheumatoid arthritis.
    Tugwell P; Idzerda L; Wells GA
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S224-36. PubMed ID: 18095786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.